MedTrace Logo

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

NCT04207931 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-03-31

No results posted yet for this study

Summary

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Conditions

  • Central Centrifugal Cicatricial Alopecia (CCCA)

Interventions

DRUG

Topical steroid class I-II

applied once daily - 18 month duration of the study

DRUG

Triamcinolone Acetonide

Intralesional Steroid Injection, 7.5mg/cc. max dose of 3 cc. Scalp injections will be administered every 6-8 weeks, for a total of 8 injections.

DRUG

Doxycyline

oral antibiotic twice daily for 6 months

DRUG

Minoxidil

5% solution or foam started after month 8

Sponsors & Collaborators

  • The Skin of Color Society

    collaborator UNKNOWN

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Amy J McMichael, MD · Wake Forest Baptist Health Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2026-11-30
Completion
2027-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04207931 on ClinicalTrials.gov